Carregant...
Cutaneous Lupus Erythematosus: Updates on Pathogenesis and Associations with Systemic Lupus
PURPOSE OF REVIEW: Cutaneous lupus erythematosus (CLE) is a common manifestation among systemic lupus patients. There are no FDA approved therapies for CLE, and these lesions are frequently disfiguring and refractory to treatment. This will review will cover the recent inroads made into understandin...
Guardat en:
| Publicat a: | Curr Opin Rheumatol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965280/ https://ncbi.nlm.nih.gov/pubmed/27270345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/BOR.0000000000000308 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|